RecruitingNANCT06665295

Randomized Controlled Trial of a Supportive Care Digital Application (THRIVE-CAR-T) for Patients Receiving CAR-T Cell Therapy

Sponsor: Patrick C. Johnson, MD

Trial Details

ConditionCAR T-Cell Therapy
InterventionTHRIVE-CAR-T
PhaseNA
StatusRecruiting
Participants100
Est. Completion1 Nov 2026
Last Updated1 Apr 2026

Primary Outcome

Feasibility

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Age 18 years or older 2. Ability to understand English 3. Diagnosis of a hematologic malignancy 4. Receiving autologous CAR-T at MGH with an FDA approved cellular therapy product Exclusion Criteria: 1. Impaired cognition or uncontrolled mental illness that prohibits the ability to provide informed consent based on the oncology clinician assessment 2. Already participating in another supportive care clinical trial

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service